about
Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic DiseasesCandidate genes of idiopathic pulmonary fibrosis: current evidence and researchPharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future PerspectivesOckham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancerLevels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments.Idiopathic pulmonary fibrosis in East Asian.Lung microbiome and host immune tone in subjects with idiopathic pulmonary fibrosis treated with inhaled interferon-γ.Second harmonic generation microscopy reveals altered collagen microstructure in usual interstitial pneumonia versus healthy lung.Induction of Connective Tissue Growth Factor Expression by Hypoxia in Human Lung Fibroblasts via the MEKK1/MEK1/ERK1/GLI-1/GLI-2 and AP-1 Pathways.Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF.Genome-wide analysis of DNA methylation and gene expression defines molecular characteristics of Crohn's disease-associated fibrosis.Apolipoprotein A1 Inhibits TGF-β1-Induced Epithelial-to-Mesenchymal Transition of Alveolar Epithelial CellsIncreased Cellular NAD+ Level through NQO1 Enzymatic Action Has Protective Effects on Bleomycin-Induced Lung Fibrosis in Mice.Cellular senescence mediates fibrotic pulmonary diseaseA Dataset of 26 Candidate Gene and Pro-Inflammatory Cytokine Variants for Association Studies in Idiopathic Pulmonary Fibrosis: Frequency Distribution in Normal Czech Population.TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases.Longitudinal "Real-World" Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece.Are newly launched pharmacotherapies efficacious in treating idiopathic pulmonary fibrosis? Or is there still more work to be done?The Expression of AQP1 IS Modified in Lung of Patients With Idiopathic Pulmonary Fibrosis: Addressing a Possible New Target.Dental Personnel Treated for Idiopathic Pulmonary Fibrosis at a Tertiary Care Center - Virginia, 2000-2015.Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review.Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis.
P2860
Q26748338-F38D573D-E02D-4613-A391-7D8B9FFB049AQ26764812-895DE463-FFD8-4BDC-AC46-1BDBD388A87DQ26771309-5CB8A405-D2AC-478F-8D13-CD142ED02BBDQ28067777-481A6F2D-63BB-44E3-A332-6CE802EAC02CQ30398970-1DFB2207-E28A-4365-A97C-8ED2F266291EQ33747908-E37D886E-10B7-4BBC-B3CB-559DA71761B6Q33897430-8C4764AA-23D1-40D9-BF59-6B2C4ACDCF27Q35682532-AE78DD90-CEEB-4903-A98F-AE7922CD0148Q36093588-1B8D5836-37FA-4209-B606-AAA9D2A3A90CQ36095068-BD4BF586-2CB4-44BB-B6D9-302456F782E4Q36680459-35FEBB3D-2DBC-4F33-A899-46C1C20CDAFFQ37092455-D0598925-D857-40FC-80B3-089A5C2B2C54Q37362342-A9D12093-BF0F-4294-9B8C-24B3E6776C6DQ37672706-BD47D9A3-19B6-4D70-A7EE-22249805E802Q42228778-25075016-B1C3-4EE0-9F9A-2EA363E6760EQ44537770-0B044A50-9D38-466A-956F-CD00E10FF6AFQ47680958-968DD5CB-FE57-42DC-B60F-A8E830A5B313Q47937434-CAA16ABE-24FE-46D6-9313-78C7F2351B6CQ53818397-6B643628-6955-40BF-9237-650760A70BAEQ55009147-3D072600-45E0-4C21-B25D-38916A139BEDQ55365053-19361CAD-06F8-4632-8F3F-88E8927C5347Q55379594-38D6EC2D-A0D3-4A40-A2A0-027DED31620C
P2860
description
im Januar 2015 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2015
@uk
name
Idiopathic pulmonary fibrosis: An update
@en
Idiopathic pulmonary fibrosis: An update
@nl
type
label
Idiopathic pulmonary fibrosis: An update
@en
Idiopathic pulmonary fibrosis: An update
@nl
prefLabel
Idiopathic pulmonary fibrosis: An update
@en
Idiopathic pulmonary fibrosis: An update
@nl
P2093
P2860
P50
P1433
P1476
Idiopathic pulmonary fibrosis: An update
@en
P2093
Argyris Tzouvelekis
Bruno Crestani
Paolo Spagnolo
P2860
P356
10.3109/07853890.2014.982165
P407
P577
2015-01-02T00:00:00Z